Document is current
Any future updates will be listed below
-
Authors
Xie, Yuanyuan
Yi, Qing
Xu, Congwang
Wang, Yaping
Jiang, Yue
Feng, Yirui
Wang, Liudi
Yang, Hui
Zhang, Yingwei
Wang, Bin https://orcid.org/0000-0003-3981-8849
-
Funding
Funding for this research was provided by:
Natural Science Foundation of Jiangsu Province of China (No. BK20230141)
National Natural Science Foundation of China (No. 82070459, No. 82270701, No. 82270076)
Nanjing Municipal Health Science and Technology Development Special Fund Project (No. YKK23108)
Clinical Research Special Fund of Nanjing Drum Tower Hospital (No. 2024-LCYJ-PY-77)
- License Information
-
More Information
Article History
Received: 9 December 2024
Accepted: 4 April 2025
First Online: 20 April 2025
Declarations
:
: Ethnic approval was granted by the Medical Ethics Committees of Nanjing Drum Tower Hospital (Project title: Utilization of Clinical Patient Samples (Tissue/Blood/Body Fluids) and Aborted Fetal Tissue to Extract Stromal Cells for Basic and Clinical Research in Regenerative Medicine and Treatment of Clinical Diseases; Approval No. 2017-161-08; Date of approval: 2017-11-30. Project title: TNFSF4(low)-MSCs Improve IPF by Regulating Tregs Subtypes; Approval No. 2023-675-01; Date of approval: 2023-03-20). All experiments involving mice were approved by the Ethics Committee of Nanjing Drum Tower Hospital (Project title: Research on the Mechanism of MSCs in Treating Pulmonary Fibrosis; Approval No. DWSY-22047178; Date of approval: 2022-04-07). All participants provided written informed consent before enrollment in the study.
: Not applicable.
: The authors declare that they have no competing interest.
